Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · December 28, 2023

Impact of Drug–Gene Interactions on Outcomes in Patients With Disorders of Gut–Brain Interactions

Neurogastroenterology and Motility


Additional Info

Neurogastroenterology and Motility
Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions
Neurogastroenterol. Motil. 2023 Dec 10;[EPub Ahead of Print], R Varma, JP Staab, ET Matey, JA Wright, B Deb, KN Lazaridis, LA Szarka, KR Bailey, AE Bharucha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading